TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02847312 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02353988 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00339989 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04470388 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00003929 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03568812 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03568812 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04041544 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04501276 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT02898922 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02898922 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study NCT02898922 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT02898922 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT02898922 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02033018 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02770495 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT01930474 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01930474 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01930474 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT01930474 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01569412 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01926132 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01926132 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01254019 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03504072 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03206671 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03061474 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00842257 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00842257 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00001354 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03795428 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02091076 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00392093 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00392093 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05542459 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT02698007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02266563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00880048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03471611 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01932450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01932450 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT03630224 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03206918 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01537003 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT03393377 — Predictive Biomarker (PRD): VCAM1 mRNA
Genes: VCAM1
Study NCT03393377 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT00588809 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00588809 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02201173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01038648 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04136470 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04136470 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04136470 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03767439 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study NCT02849535 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03974074 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04389073 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02504372 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03971929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00353080 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02552576 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04231448 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT04231448 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT01829568 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04414098 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03035123 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01755949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03654222 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT04677322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01904721 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT00812526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02867566 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03368066 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study NCT05314296 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00173914 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT03606486 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03606486 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00446329 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03129542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01508910 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02608528 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02608528 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03555877 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03555877 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04151407 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02165761 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT03070483 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03070483 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03070483 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02685397 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06056908 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT01460563 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04391283 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04391283 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04100408 — Predictive Biomarker (PRD): SMAD6 mRNA
Genes: SMAD6; MADH6
Study NCT06357975 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01763892 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03546634 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04396821 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT03047083 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01801449 — Safety Biomarker (SAF): Interleukin 1
Study NCT01924026 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02703714 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04057196 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT01306526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04632368 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study NCT03988036 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01944020 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04909554 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01091233 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01091233 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01091233 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03446898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00092014 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05250336 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05250336 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00573339 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01063036 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00003339 — Safety Biomarker (SAF): Interleukin 12
Study NCT02814643 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT02818517 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04395326 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02834429 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02402595 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02402595 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01209819 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01209819 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01213082 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01701453 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00337038 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03688685 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study NCT03443635 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT02039011 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT02035514 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04566458 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03020745 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00644709 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01523405 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02125344 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00609752 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03368196 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01767896 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03856866 — Predictive Biomarker (PRD): PEX1 mRNA
Genes: PEX1
Study NCT03856866 — Predictive Biomarker (PRD): PEX6 mRNA
Genes: PEX6; PXAAA1
Study NCT03856866 — Predictive Biomarker (PRD): PEX26 mRNA
Genes: PEX26
Study NCT02573636 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT02573636 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01929200 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00662480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00676234 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00676234 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00229268 — Predictive Biomarker (PRD): FOXA2 mRNA
Genes: FOXA2; HNF3B; TCF3B
Study NCT04819815 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02157428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00202579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02332473 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01686113 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02435654 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study NCT02435654 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT02435654 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT02592421 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00638573 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00587041 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT02537704 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03475602 — Predictive Biomarker (PRD): THSD7A mRNA
Genes: THSD7A; KIAA0960
Study NCT00717847 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00717847 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03296332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02562781 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04820439 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00997789 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT04419467 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01147380 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03783754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04505982 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT04505982 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04505982 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04505982 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT04505982 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00004266 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03760835 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04707079 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01471964 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT03603158 — Predictive Biomarker (PRD): KCNH2 mRNA
Genes: KCNH2; ERG; ERG1; HERG
Study NCT03255096 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT03255096 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT03255096 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study NCT02368171 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT02368171 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02368171 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00311207 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study NCT03710421 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02627183 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02627183 — Safety Biomarker (SAF): BDNF
Study NCT00962871 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01987466 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04421404 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04408898 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04217018 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03399370 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03399370 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04088032 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01773928 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT05795270 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT01103856 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03069378 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01038505 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT01202955 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01682356 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01682356 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT04488783 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04488783 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01646541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02359006 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00301990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00301990 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01348880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04813731 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01656096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02545439 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00030888 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT01350804 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01641107 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00065260 — Surrogate Endpoint (SUR): Hematologic response
Study NCT01538719 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT01538719 — Predictive Biomarker (PRD): IFI44 mRNA
Genes: IFI44; MTAP44
Study NCT01538719 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01746355 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02999477 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01827787 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03341637 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02101905 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02759445 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT01091454 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01091454 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03470350 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04023292 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04023292 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02748681 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03696771 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00369837 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03256721 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03256721 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT04157699 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04315090 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04563156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01658553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01448538 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01448538 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04978987 — Predictive Biomarker (PRD): PLN mRNA
Genes: PLN; PLB
Study NCT01998061 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01998061 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04560855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02491177 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04393142 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02620761 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00203372 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00203372 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT00203372 — Predictive Biomarker (PRD): TMEM37 mRNA
Genes: TMEM37; PR
Study NCT03603184 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03692013 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000152 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00484341 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02735291 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study NCT03763734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01173510 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT00313495 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02449941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02462369 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS